Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-15-034588
Filing Date
2015-04-16
Accepted
2015-04-16 16:25:34
Documents
1
Period of Report
2015-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4171
  Complete submission text file 0001209191-15-034588.txt   5578
Mailing Address C/O AEGERION PHARMACEUTICALS 89 HEADQUARTERS PLAZA, SUITE 1212 MORRISTOWN NJ 07960
Business Address
Beer Marc D (Reporting) CIK: 0001314575 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36517 | Film No.: 15775262

Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Issuer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations